|Bid||69.65 x 800|
|Ask||69.66 x 800|
|Day's range||69.04 - 69.69|
|52-week range||63.92 - 88.78|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||75.61|
|Forward dividend & yield||0.21 (0.30%)|
|Ex-dividend date||03 May 2022|
|1y target est||85.83|
Alcon's (ALC) robust innovation pipeline is delivering solid results as evidenced by the successful launch of new ATIOL roles and SiHy contact lenses.
GENEVA, August 09, 2022--Alcon Reports Second Quarter 2022 Results
Robust retail and pharmacy sales performance are likely to have driven CVS Health's (CVS) Q2 performance.